Sort
11,323 grants matching “glioblastoma”
Administrative Core
$246,805Li Ding · Washington University · U2C · FY2020 · CA
Targeting OGDH for Glioblastoma Therapy
$246,750Markus D Siegelin · Columbia University Health Sciences · R21 · FY2024 · NS
Dissecting Glioma Genesis through a Glial-Specific Mouse Model
$246,657Wei Zhang · University Of Tx Md Anderson Can Ctr · R56 · FY2009 · CA
X-ray/optical tomographic guidance and assessment for pre-clinical radiation Research
$246,583Ken Kang-Hsin Wang · Ut Southwestern Medical Center · R37 · FY2020 · CA
Revealing new regulators of EGFR-P13K driven glioma proliferation and migration
$246,511Renee D Read · Emory University · R00 · FY2014 · NS
Coordinating Translesion DNA Synthesis Opposite Damaged DNA
$246,313Robert L Eoff · Univ Of Arkansas For Med Scis · R00 · FY2012 · GM
Identification of glioma tumor-initiating cells
$246,250Michael K Cooper · Vanderbilt University · R21 · FY2010 · NS
Reviving cancer immune surveillance with CD4 T cell help
$246,243Michael Clavon Brown · Duke University · R00 · FY2023 · CA
TUMOR SPECIFIC TARGET FOR THERAPEUTIC DELIVERIES
$246,146Pennsylvania State Univ Hershey Med Ctr · R01 · FY2000 · CA
Targeting Glioma by Anti-MMPs-2 and -9 DNAzymes
$246,068Tayebeh Pourmotabbed · University Of Tennessee Health Sci Ctr · R01 · FY2007 · CA
Targeting Glioma by Anti-MMPs-2 and -9 DNAzymes
$246,068Tayebeh Pourmotabbed · University Of Tennessee Health Sci Ctr · R01 · FY2009 · CA
Targeting Glioma by Anti-MMPs-2 and -9 DNAzymes
$246,068Tayebeh Pourmotabbed · University Of Tennessee Health Sci Ctr · R01 · FY2008 · CA
Role of PKCeta in Regulating Astrocytoma Invasive Growth
$246,050University Of Virginia Charlottesville · R01 · FY2005 · CA
Role of PKCeta in Regulating Astrocytoma Invasive Growth
$246,050University Of Virginia Charlottesville · R01 · FY2004 · CA
Role of PKCeta in Regulating Astrocytoma Invasive Growth
$246,050University Of Virginia Charlottesville · R01 · FY2003 · CA
Role of PKCeta in Regulating Astrocytoma Invasive Growth
$246,050University Of Virginia Charlottesville · R01 · FY2002 · CA
Targeting Translation Control in Malignant Glioma
$246,045Matthias Gromeier · Duke University · R01 · FY2014 · CA
CMV Therapeutic Vaccine for the Treatment of Glioblastoma
$246,026John H Sampson · Annias Immunotherapeutics, Inc. · R41 · FY2012 · CA
Inhibiting Notch activity and brain tumor progression using Zen Sheng Ping (ZSP)
$246,000Charles George Eberhart · Johns Hopkins University · R21 · FY2008 · AT
Novel Therapeutic Agents for Gliomas with IDH Mutations
$246,000Takashi Tsukamoto · Johns Hopkins University · R21 · FY2011 · NS
Novel Therapeutic Agents for Gliomas with IDH Mutations
$246,000Takashi Tsukamoto · Johns Hopkins University · R21 · FY2012 · NS
MDM2 inhibitor therapy for TP53 wild-type GBM
$245,952Jann N Sarkaria · Mayo Clinic Rochester · U19 · FY2023 · CA
Noninvasive measurement of oncogenic signaling pathways with 89Zr-transferrin
$245,941Michael John Evans · University Of California, San Francisco · R00 · FY2015 · CA
Defining the Hypoxic Immunosuppressive Microenvironment as a Biomarker of Therapy Efficacy in Glioblastoma Using Iron Oxide Enhanced FMISO PET/MRI
$245,663Ramon Francisco Barajas · Oregon Health & Science University · K08 · FY2022 · CA
Defining the Hypoxic Immunosuppressive Microenvironment as a Biomarker of Therapy Efficacy in Glioblastoma Using Iron Oxide Enhanced FMISO PET/MRI
$245,663Ramon Francisco Barajas · Oregon Health & Science University · K08 · FY2020 · CA